ImmunoPET imaging for pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests a new imaging method called ImmunoPET to see if it can help detect pancreatic cancer more clearly. If you have or might have pancreatic cancer, this study could help doctors understand your condition better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with pancreatic cancer through a biopsy, or your doctor thinks you might have it based on scans.
- You are willing to sign a consent form agreeing to the study's rules.
- You are not allergic to the study drugs or their components.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan (68Ga-grazytracer) to see how well immunotherapy is working for pancreatic cancer. It may help your doctor understand if your treatment is effective.
This trial uses a special imaging test (PET scan) to find digestive system cancers. It uses molecules that attach to cancer cells so they light up on the scan, which may help doctors see tumors more clearly.
This Phase 1 trial tests a new imaging agent (a radioactive tracer) that helps doctors see pancreatic cancer that has spread or cannot be removed by surgery. The scan uses positron emission tomography (PET), a type of imaging that detects cancer cells.
This trial tests a new type of PET scan that uses a special tracer (FAPI) to get clearer images of pancreatic cancer. The goal is to find cancer earlier and better plan surgery or treatment.
This study tests a new type of PET scan that uses a radioactive tracer called FAPI-74 to find cancer spread in people with pancreatic cancer. The goal is to see if this scan can help doctors better plan treatment.
This trial tests two new radioactive imaging scans (called PET scans) designed to better detect certain advanced cancers like pancreatic, lung, breast, colon, or soft-tissue tumors. The goal is to see if these scans help doctors find and track cancer more accurately than standard imaging.
Hear when a new Neoplasms Pancreatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.